Login / Signup

Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy.

Giuseppe DanieleCarolina Solis-HerreraAngela DardanoAndrea MariAndrea TuraLaura GiustiJancy J KurumthodathuBeatrice CampiAlessandro SabaAnna Maria BianchiCarla TregnaghiMaria Francesca EgidiMuhammad Abdul-GhaniRalph DeFronzoStephano Del Prato
Published in: Diabetologia (2020)
ClinicalTrials.gov NCT03168295 FUNDING: This protocol was supported by Qatar National Research Fund (QNRF) Award No. NPRP 8-311-3-062 and NIH grant DK024092-38. Graphical abstract.
Keyphrases
  • kidney transplantation
  • robot assisted
  • health insurance
  • quality improvement
  • randomized controlled trial
  • blood glucose
  • editorial comment
  • case report
  • metabolic syndrome